FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.
Wang Y, Zhang W, Wen L, Yang H, Wen M, Yun Y, Zhao L, Zhu X, Tian L, Luo E, Li Y, Liu W, Wen N.
Wang Y, et al. Among authors: wen l, wen m, wen n.
Oncotarget. 2016 Sep 13;7(37):59245-59259. doi: 10.18632/oncotarget.11043.
Oncotarget. 2016.
PMID: 27494877
Free PMC article.